Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis
Abstract Background Recent evidence suggests that biologic therapy with targeted activity within the Type 2 inflammatory pathway can improve the clinical signs and symptoms of chronic rhinosinusitis with nasal polyposis (CRSwNP). There remains a population in CRSwNP that despite medical therapy and...
Saved in:
Main Authors: | Andrew Thamboo, S. Kilty, I. Witterick, Y. Chan, C. J. Chin, A. Janjua, A. Javer, J. Lee, E. Monterio, B. Rotenberg, J. Scott, K. Smith, D. D. Sommer, L. Sowerby, M. Tewfik, E. Wright, M. Desrosiers |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-03-01
|
Series: | Journal of Otolaryngology - Head and Neck Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40463-021-00493-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Remission: does it already exist in chronic rhinosinusitis with nasal polyposis?
by: Yvonne Chan, et al.
Published: (2023-07-01) -
Resection versus preservation of the middle turbinate in surgery for chronic rhinosinusitis with nasal polyposis: a randomized controlled trial
by: Marc-Antoine Hudon, et al.
Published: (2018-11-01) -
Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps
by: Shaun J. Kilty, et al.
Published: (2022-04-01) -
Murine model for chronic rhinosinusitis: an interventional study
by: Amr F. Hamour, et al.
Published: (2023-04-01) -
Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease – a randomized crossover trial
by: Leigh J. Sowerby, et al.
Published: (2021-04-01)